Primary amoebic meningoencephalitis caused by Naegleria. Two new cases, response to amphotericin B, and a review.
D000293:Adolescent; D000328:Adult; D000562:Amebiasis / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D000563:Amebicides / Q000627:therapeutic use; D000656:Amoeba; D000666:Amphotericin B / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001921:Brain / Q000473:pathology; D002555:Cerebrospinal Fluid / Q000382:microbiology; D004781:Environmental Exposure; D005260:Female; D006801:Humans; D008297:Male; D008590:Meningoencephalitis / Q000188:drug therapy* / Q000382:microbiology* / Q000473:pathology; D009297:Nasal Mucosa / Q000473:pathology; D013116:Spinal Cord / Q000473:pathology; D013551:Swimming Pools; D014768:Virginia
D000563:Amebicides; D000900:Anti-Bacterial Agents; D000666:Amphotericin B